SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Wood Mark

(Last)

(First)

(Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

105 DIGITAL DRIVE

(Street)

NOVATO

94949

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2013

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/22/2013⁽¹⁾	04/22/2013	M		937	A	$14.39	24,182	D
Common Stock	04/22/2013⁽¹⁾	04/22/2013	M		833	A	$21.51	25,015	D
Common Stock	04/22/2013⁽¹⁾	04/22/2013	M		812	A	$26.49	25,827	D
Common Stock	04/22/2013⁽¹⁾	04/22/2013	M		520	A	$37.46	26,347	D
Common Stock	04/22/2013⁽¹⁾	04/22/2013	S		3,102	D	$65.5748⁽²⁾	23,245	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy) Common Stock	$14.39	04/22/2013⁽¹⁾	04/22/2013	M			937	11/12/2009⁽³⁾	05/11/2019	Common Stock	937	$0	938⁽⁷⁾	D
Stock Option (right to buy) Common Stock	$21.51	04/22/2013⁽¹⁾	04/22/2013	M			833	11/12/2010⁽⁴⁾	05/11/2020	Common Stock	833	$0	10,837⁽⁷⁾	D
Stock Option (right to buy)	$26.49	04/22/2013⁽¹⁾	04/22/2013	M			812	11/12/2011⁽⁵⁾	05/11/2021	Common Stock	812	$0	20,317⁽⁷⁾	D
Stock Option (right to buy) Common Stock	$37.46	04/22/2013⁽¹⁾	04/22/2013	M			520	11/08/2012⁽⁶⁾	05/07/2022	Common Stock	520	$0	19,275⁽⁷⁾	D

Explanation of Responses:

1. Transaction made pursuant to a Rule 10b5-1 plan executed on August 13, 2012.

2. The price in Column 4 is a weighted average price. The prices actually received ranged from $65.01 to $66.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

3. Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.

4. Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter. Remarks:

5. Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.

6. Original option grant vests 6/48th on November 8, 2012 and 1/48th each on the 8th of each month thereafter.

7. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.

Remarks:

	/s/ Laura Woodhead, Attorney-in-Fact	04/23/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.